Abo Bibliothek: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Alternative Propellant Aerosol Delivery Systems

Volumen 22, Ausgabe 6, 2005, pp. 493-534
DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i6.10
Get accessGet access

ABSTRAKT

The year 2006 represents the 50th anniversary of the pressurized metered dose inhaler. With most technologies, 50 years represents a significant time span for technology evolution and modification, but with propellant-driven metered dose inhalers, the pace of change has been relatively slow. We are now in the era of alternative propellant aerosol delivery systems, but at this 50-year juncture, what are the characteristics of these systems and what are the prospects for future advances? This review will consider alternative propellant aerosol delivery systems broadly from their inception through future opportunities and challenges.

REFERENZIERT VON
  1. Hindle Michael, Aerosol Drug Delivery, in Pharmaceutical Sciences Encyclopedia, 2010. Crossref

  2. Dolovich Myrna B., Aerosols and Aerosol Drug Delivery Systems, in Middleton's Allergy: Principles and Practice, 2009. Crossref

  3. Kleinstreuer Clement, Zhang Zhe, Optimal Drug-Aerosol Delivery to Predetermined Lung Sites, Journal of Heat Transfer, 133, 1, 2011. Crossref

  4. Crowder Timothy M., Donovan Martin J., Science and Technology of Dry Powder Inhalers, in Controlled Pulmonary Drug Delivery, 2011. Crossref

  5. Kleinstreuer C., Zhang Z., Donohue J.F., Targeted Drug-Aerosol Delivery in the Human Respiratory System, Annual Review of Biomedical Engineering, 10, 1, 2008. Crossref

  6. Donovan Martin J, Gibbons Aileen, Herpin Matthew J, Marek Stephen, McGill Shayna L, Smyth Hugh DC, Novel dry powder inhaler particle-dispersion systems, Therapeutic Delivery, 2, 10, 2011. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain